Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
28.21
-0.28 (-0.98%)
Apr 24, 2026, 11:58 AM EDT - Market open
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $2.33 billion as of April 24, 2026. Its market cap has increased by 205.24% in one year.
Market Cap
2.33B
Enterprise Value
1.69B
1-Year Change
205.24%
Ranking
Category
Stock Price
$28.21
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $2.33B, an increase of 272.21%. That is a compound annual growth rate of 50.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 2.35B | -18.21% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradermics | 2.59B |
| ADMA Biologics | 2.57B |
| Zai Lab | 2.46B |
| Ultragenyx Pharmaceutical | 2.38B |
| Definium Therapeutics | 2.32B |
| Day One Biopharmaceuticals | 2.22B |
| Tyra Biosciences | 2.18B |
| Ascentage Pharma Group International | 2.15B |